Relative binding avidity of the OspA163–175 peptide to seven HLA-DRB molecules that demonstrated strong to weak binding of the peptide. The half max binding concentration of the B. burgdorferi OspA peptide for each MHC molecule is shown with error bars (SD). The sequence of the OspA peptide was KGYVLEGTLTAEK. The positive control peptide for the B1*0401, 0402, 0404, and 0405 molecules was glutamic acid decarboxylase 65555–567 (NFIRMVISNPAAT). For the B1*0101 and 0102 molecules, it was artificial peptide-0102 (PKYVKLNALKLAT), and for the B5*0101 molecule, it was influenza hemagglutinin307–319 (PKYVKQNTLKLAT). The negative control peptide for the B1*0101 and 0102 and B5*0101 molecules was OspA165A (KGAVLEGTLTAEK). For the B1*0401, 0404, and 0405 molecules, it was retinal S-antigen peptide-14 (HVIFKKISRDKS), and for the B1*0402 molecule, it was Herpes simplex viral protein 1634–44 (PLYATGRLSQA). Data are not depicted for six HLA-DRB molecules that had negligible binding (DRB1*1101; half max = 48 μM) or no detectable binding (half max of ≥50 μM; DRB1*0301, 0701, 1104, 1501, and DRB4*0101) of the OspA peptide. With each of these DRB molecules, the positive control peptide showed strong binding, and the negative control peptide showed no detectable binding.